Furthermore, the production of the anti-tumoral GM-CSF is controlled by the E3 promoter, which in turn is dependent on the expression of the E1a gene product, resulting in E2F-1 dependent, and therefore tumor-selective, GM-CSF expression (223). The gene discussed is CSF2; the disease is neoplasm.